Dons Dizon News Today

The combination of nivolumab and ipilimumab improved responses as well as survival outcomes in patients with ovarian or gynecologic clear cell carcinomas.

Don S. Dizon, MD, FACP, FASCO, discusses future directions for precision medicine approaches in ovarian cancer.

Many women with cancer want advice for managing sexual function issues, and clinicians are tuning in, new studies suggest.

Don S. Dizon, MD, on the prevalence of sexual complications in patients with breast cancer.

Over the last year, prestigious national and international organizations recognized Brown faculty for their research, scholarship and leadership.

Discover how doctors market themselves and their practices on social media to connect with patients, provide accurate, thoughtful medical information, and grow their practice.

Patient advocate Kristin Flanary, aka "Lady Glaucomflecken," will deliver the keynote speech, titled "Wife and Death," at the UVM Cancer Centers 26th annual Women’s Health and Cancer Conference on Sept.

Los Angeles, CA (PRWEB) December 15, 2022 -- Breaking News!Podcast Launch! The Glaucomfleckens are launching the “Knock Knock Hi” podcast!Whether

There's a misconception that I frequently hear about evidence-based medicine (EBM), which can equally apply to science-based medicine (SBM). Actually, there are several, but they are related. These misconceptions include the idea that EBM/SBM guidelines are a straightjacket, that they are "cookbook medicine," and that EBM/SBM should be the be-all and end-all of how to practice clinical medicine. New readers might not be familiar with the difference between EBM and SBM, and here is...

A Twitter post calling out an exchange between a presenter and an attendee asking questions at the recent GUCS conference created a bit of a buzz.